Skip to main content
Clinical Trials/RBR-8wmvbnw
RBR-8wmvbnw
Active, not recruiting
未知

Behavioral and electrophysiological evaluation of Auditory Processing in patients with Type 1 Neurofibromatosis before and after auditory training

niversidade Federal de São Paulo0 sitesJune 11, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
eurofibromatosis (non-malignant)
Sponsor
niversidade Federal de São Paulo
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2021
End Date
November 19, 2020
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de São Paulo

Eligibility Criteria

Inclusion Criteria

  • Individuals aged 9 to 35 years old, presenting a medical diagnosis of type 1 neurofibromatosis; present auditory thresholds less than or equal to 15 dBHL between 250 and 4000Hz, bilaterally, characterizing audibility thresholds within the normal range; to present type A tympanometric curves, bilaterally, featuring adequate functioning of the middle ear; present Central Auditory Processing Disorder.

Exclusion Criteria

  • Neurofibromatosis type 1 patients with comorbidities such as Attention Deficit Hyperactivity Disorder, autism and intellectual disability; perform radiotherapy or chemotherapy that compromises peripheral hearing; the presence of epileptic seizures and epilepsy not controlled by a medical team; present alteration of the middle ear; have previously undergone any format of rehabilitation of central auditory processing.

Outcomes

Primary Outcomes

Not specified

Similar Trials